Table 3.
Outcomes for recipients from donors with (A) persistent, (B) non-persistent SARS-CoV-2 infection at transplantation, and (C) only from lung transplant donors.
| (A) Persistent SARS-CoV-2 infection | |||||||
|---|---|---|---|---|---|---|---|
| Author, year [ref] | N recipients | Organ Transplanted (n) | Hospitalisation, days | Complications (n) |
Symptoms (Post operation) |
Mortality (n) |
Viral transmission |
| Hong, 2020 [19] | 1 | Liver (1) | 69a | Peritonitis, coronary occlusion | No | Alive | No |
| Puodziukaite, 2021 [10] | 2 | Kidney (2) | 18 | Delayed graft function (1) | No | Alive | No |
| Romagnoli, 2021 [9] | 8 | Liver (8) | 14.5 (10.2−25.5)* | Septic shock (1) | No | Death (1)/Alive (7) | No |
| (B) Non-Persistent SARS-CoV-2 infection | |||||||
|---|---|---|---|---|---|---|---|
| Author, year [ref] | N recipients | Organ Transplanted (n) | Hospitalisation, days | Complications (n) |
Symptoms (Post operation) |
Mortality (n) |
Viral transmission |
| Neidlinger, 2021 [28] | 13 | Liver (4), Heart (3), Kidney (6) | – | Multisystem organ failure (1) Delayed graft function (1) |
No | Death (1)/Alive (12) | No |
| Kucuk, 2021 [21] | 1 | Kidney (1) | 15 | No | No | Alive | No |
| Nguyen, 2021 [17] | 1 | Liver (1) | 13 | No | No | Alive | No |
| Kute, 2021 [22] | 31 | Kidney (31) | – | Acute rejection (2) | No | Alive | No |
| Manzia, 2021 [11] | 1 | Liver (1) | 56a | Obstructive jaundice Renal impairment |
No | Alive | No |
| La Hoz, 2022 [20] | 2 | Liver (2) | – | Biliary stricture (1) | No | Alive | No |
| Perlin, 2021 [24] | 2 | Kidney (2) | 35 | Delayed graft function (1) Genital herpes (1) |
No | Alive | No |
| Tuncer, 2021 [18] | 1 | Liver (1) | 16a | No | No | Alive | No |
| Koval, 2021 [23] | 6 | Kidney (6) | – | Delayed graft function (1) Ileus (1) |
No | Alive | No |
| (C) Lung transplant donors | |||||||
|---|---|---|---|---|---|---|---|
| Author, year [ref] | N recipients | Organ Transplanted (n) | Hospitalisation, days | Complications (n) |
Symptoms (Post operation) |
Mortality (n) |
Viral transmission |
| Querrey, 2021 [25] | 1 | Lung | 40ª | Pleural effusions | No | Alive | No |
| Ceulemans, 2021 [27] | 1 | Lung | 35 | Acute rejection Pneumothorax (dislocated tube) | No | Alive | No |
| Kaul, 2021 [26] | 1 | Lung | 61 | Septic shock Multisystem organ failure |
Yes | Death | Yes |
| Kumar, 2021 [29] | 1 | Lung | 25ª | Bilateral airspace disease | Yes | Alive | Yes |
| Eichenberger, 2021 [30] | 1 | Lung | – | – | – | Alive | Yes |
*
Data reported as median (interquartile range).
a
Last follow update reported. To this day, the patient was still hospitalised.